Medscape

Filtered Pump Sets and Flolan (Epoprostenol) Interruption

Epoprostenol (FLOLAN) is an intravenous medication used to treat primary pulmonary hypertension (PPH), a condition characterized by progressive increases in pulmonary artery pressure, leading to right ...
Medscape

Epoprostenol improves survival in primary pulmonary hypertension

Dallas, TX - As new agents are developed for the treatment of primary pulmonary hypertension (PPH), long-term data are now becoming available on the first drug approved for this indication, ...
Business Wire

GlaxoSmithKline and Myogen Announce Pulmonary Arterial Hypertension Partnership; GlaxoSmithKline to Commercialize Ambrisentan in All Territories Outside of the U.S.

Myogen Receives Flolan Rights in U.S. and Will Launch Commercial Operations in Q2 '06 GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Myogen, Inc. (Nasdaq: MYOG) today announced a two-part collaboration in ...
EurekAlert!

First oral drug proven effective in treating primary pulmonary hypertension

A first-of-its-kind oral drug has been shown to successfully treat primary pulmonary hypertension (PPH), according to the results of a multi-center trial led by UCSD School of Medicine pulmonary ...